FIBROGEN INC — Director's Dealing 2016

Feb 10, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2016-02-05

Reporting Person: Yu K Peony (VP, Clinical Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-02-05	Common Stock	M	6000	$3.50	Acquired	182595	Direct
2016-02-05	Common Stock	M	4500	$5.95	Acquired	187095	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-02-05	Stock Option (Right to Buy)	$3.50	M	6000	Disposed	2021-06-07	Common Stock (6000)	Direct
2016-02-05	Stock Option (Right to Buy)	$5.95	M	4500	Disposed	2022-06-27	Common Stock (4500)	Direct

Footnotes

F1: Fully vested.